- Net loss widened to $25.8M ($0.20/share) vs. $18.0M ($0.21/share) YoY.
- Cash and equivalents stood at $187.7M, supported by prior financing.
- Phase 2 TibuSHIELD and TibuSURE enrollment completed, data on track for Q4 2026 and H1 2027.
? Neutral AI Sentiment (-0.5 / 10)